terikalant has been researched along with Cardiovascular Stroke in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gross, GJ; Hsu, AK; Kwok, WM; Schultz, JE | 1 |
1 other study(ies) available for terikalant and Cardiovascular Stroke
| Article | Year |
|---|---|
Terikalant, an inward-rectifier potassium channel blocker, does not abolish the cardioprotection induced by ischemic preconditioning in the rat.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; ATP-Binding Cassette Transporters; Cells, Cultured; Chromans; Electrophysiology; Guinea Pigs; Heart; Hemodynamics; Ischemic Preconditioning, Myocardial; KATP Channels; Male; Myocardial Infarction; Piperidines; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar | 1998 |